John Spirnak, MD
Urology · Middleburg Heights, OHNPI 1295724136
Payments from drug & device makers
Across 17 payments — averaging $21.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$68
- Laborie Medical Technologies Corp.$60
- Verity Pharmaceuticals Inc.$57
- Boston Scientific$55
- Dendreon Pharmaceuticals LLC$35
- AbbVie$18
- plus $72 from 5 others
What the payments were for
- Food & beverage$31185%
- Education$5415%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 2 | $68 |
| Laborie Medical Technologies Corp. | 3 | $60 |
| Verity Pharmaceuticals Inc. | 3 | $57 |
| Boston Scientific | 2 | $55 |
| Dendreon Pharmaceuticals LLC | 1 | $35 |
| AbbVie | 1 | $18 |
| Calyxo, Inc. | 1 | $15 |
| Bayer | 1 | $15 |
| Blue Earth Diagnostics | 1 | $15 |
| Sun Pharmaceutical Industries Inc. | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
How this compares
$365 in reported general payments places this provider in the 15th percentile of 485 urology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 96 | $65,031 |
| Tamsulosin Hcl | 886 | $15,613 |
| Trospium Chloride | 150 | $11,175 |
| Finasteride | 366 | $4,571 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 161 | $3,373 |
| Potassium Citrate ErPotassium Citrate | 17 | $2,404 |
| Dutasteride | 64 | $1,784 |
| Terazosin Hcl | 29 | $652 |
| Oxybutynin Chloride ErOxybutynin Chloride | 24 | $600 |
| Solifenacin Succinate | 16 | $471 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 38 | $460 |
| Tadalafil | 11 | $429 |
| Doxazosin Mesylate | 18 | $307 |
| Cephalexin | 28 | $191 |
| Acetic Acid | 14 | $180 |
Paid to pharmacies, not to this prescriber.
Other urology in Middleburg Heights
- Lawrence GervasiMiddleburg Heights$4.7M
- Marc PliskinCincinnati$20.8M
- Martin FritzhandCincinnati$4.6M
- Kamal PoharCincinnati$3.4M
- Eric SingerColumbus$2.1M
- Benjamin MartinGahanna$1.1M
- Howard GoldmanCleveland$747K
- Jihad KaoukCleveland$696K
- Raymond RackleyCleveland$695K
- Sandip VasavadaCleveland$512K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.